This topic contains a solution. Click here to go to the answer

Author Question: After teaching a group of nursing students about antiarrhythmics, the instructor determines that the ... (Read 107 times)

HudsonKB16

  • Hero Member
  • *****
  • Posts: 535
After teaching a group of nursing students about antiarrhythmics, the instructor determines that the teaching was successful when the students identify which of the following as a class IA antiarrhythmic? Select all that apply.
 
  A) Quinidine (Quinaglute)
  B) Lidocaine (Xylocaine)
  C) Propafenone (Rythmol)
  D) Disopyramide (Norpace)
  E) Flecainide (Tambocor)

Question 2

When evaluating a client who is receiving antiarrhythmic therapy, which of the following would the nurse interpret as an expected outcome? Select all that apply.
 
  A) No evidence of injury is seen.
  B) No evidence of infection is seen.
  C) Client is free of nausea.
  D) Client urinates adequately.
  E) Oral mucous membranes are intact and moist.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eazy416

  • Sr. Member
  • ****
  • Posts: 360
Answer to Question 1

Ans: A, D
Feedback:
Class IA antiarrhythmics include disopyramide and quinidine. Lidocaine is a class IB drug. Propafenone and flecainide are class IC drugs.

Answer to Question 2

Ans: A, B, C, D, E
Feedback:
Absence of injury, infection, and nausea; adequate renal function; and intact, moist oral mucous membranes are expected outcomes for antiarrhythmic therapy.





 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library